Transfusion and Apheresis Science
Volume 35, Issue 1 , Pages 25-31 , August 2006

Cytapheresis in the treatment of cell-affected blood disorders and abnormalities

  • Bela Balint

      Affiliations

    • Department of Experimental Hematology, Institute for Medical Research, Belgrade, Serbia and Montenegro
    • Military Medical Academy, Belgrade, Serbia and Montenegro
    • Corresponding Author InformationCorresponding author. Address: Institute for Medical Research, Dr. Subotica, PO Box 102, 11 129 Belgrade, Serbia and Montenegro. Tel.: +381 63 8228 666; fax: +381 11 643 691.
    • ,
  • Gordana Ostojic

      Affiliations

    • Military Medical Academy, Belgrade, Serbia and Montenegro
    • ,
  • Mirjana Pavlovic

      Affiliations

    • Department of Biological Sciences, Center for Molecular Biology and Biotechnology, Florida Atlantic University, Boca Raton, USA
    • ,
  • Rajko Hrvacevic

      Affiliations

    • Military Medical Academy, Belgrade, Serbia and Montenegro
    • ,
  • Miodrag Pavlovic

      Affiliations

    • Clinic of Infectiosus and Tropical diseases University Clinical Center, Belgrade, Serbia and Montenegro
    • ,
  • Ljiljana Tukic

      Affiliations

    • Military Medical Academy, Belgrade, Serbia and Montenegro
    • ,
  • Milan Radovic

      Affiliations

    • Military Medical Academy, Belgrade, Serbia and Montenegro
    • Deceased.

Received 24 November 2005 ,Revised 3 March 2006 ,Accepted 3 March 2006.

References 

  1. Klein HG. Therapeutic hemapheresis. In:  Petz LD,  Swisher SN,  Kleiman S,  Spence RK,  Strauss RG editor. Clinical practice of transfusion medicine. 3rd ed.. New York: Churchill Livingstone; 1996;p. 1011–1022
  2. Valbonesi M, Pineda AA, Biggs JC. Therapeutic apheresis. Milano: Wichtig Editore; 1986;
  3. Wetsphal RG, Kasprisin DO. Current status of hemapheresis: Indications, technology and complications. Bethesda, MD: AABB Press; 1987;
  4. Balint B, Radovic M. Cytaphereses and their use in therapy. Bulet Haematol Transfus. 1990;18:81–88
  5. Radovic M, Balint B, Milenkovic L, Tiska-Rudman L, Taseski J. Therapeutic leukapheresis. Transf Sci. 1991;12:193–196
  6. Radovic M, Tiska-Rudman L, Balint B. Apheresis – Help in the treatment of malignant tumors. In:  Capri A,  Sagripanti A,  Mittermayer C editor. Advances in management of malignancies. Bologna: Monduzzi editore; 1991;p. 713–719
  7. Taseski J, Balint B, Vucetic D, Malesevic M. The application of therapeutic apheresis for treatment of hematological disorders. J Soc Franc Transf Sang. 2001;8(Suppl. 1):119s
  8. Balint B. The National Apheresis Group. Apheresis in donor and therapeutic settings: recruitments vs. possibilities – a multicenter study. Transf Apher Sci. 2005;33(2):229–237
  9. Agishi T. The current status of extracorporeal immunomodulation. Transf Sci. 1996;17:439–444
  10. Bosch T. Current status in extracorporeal immunomodulation: immune disorders. Artif Organs. 1996;20:902–905
  11. Knobler R. Extracorporeal photochemotherapy – present and future. Vox Sang. 2000;78(Suppl. 2):197–201
  12. Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study. J Gastroenterol. 2004;39(12):1158–1164
  13. Nakamura T, Kawagoe Y, Matsuda T, Ueda A, Ueda Y, Takahashi Y, et al. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis. Blood Purif. 2004;22(6):499–504
  14. Premchand P, Takeuchi K, Bjarnason I. Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis. Eur J Gastroenterol Hepatol. 2004;16(9):943–945
  15. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci. 2004;49(4):565–571
  16. Balint B. Principles of the intensive haemotherapy. Belgrade: MMA/MSCG-Press; 2004;
  17. Kleinman S, Thompson-Breton R, Breen D, Hurvitz C, Goldfinger D. Exchange red blood cell pheresis in a pediatric patient with severe complications of sickle cell anemia. Transfusion. 1981;21(4):443–446
  18. Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher. 2002;6(1):24–31
  19. Tiftik N, Altintas E, Kiykim A, Ucbilek E, Sezgin O. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report. J Clin Apher. 2004;19(1):17–19
  20. Machtinger L, Telford SR, Inducil C, Klapper E, Pepkowitz SH, Goldfinger D. Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient. J Clin Apher. 1993;8(2):78–81
  21. Golden PJ, Weinstein R. Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange. J Clin Apher. 1998;13(1):28–31
  22. Nester TA, Rumsey DM, Howell CC, Gilligan DM, Drachman JG, Maier RV, et al. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin. Transfusion. 2004;44(12):1720–1723
  23. Eichbaum QG, Dzik WH, Chung RT, Szczepiorkowski ZM. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria. Transfusion. 2005;45(2):208–213
  24. Tejura B, Sass DA, Fischer RA, Daskal I, Eiger G. Transfusion-associated falciparum malaria successfully treated with red blood cell exchange transfusion. Am J Med Sci. 2000;320(5):337–341
  25. Boctor FN. Red blood cell exchange transfusion as an adjunct treatment for severe pediatric falciparum malaria, using automated or manual procedures. Pediatrics. 2005;116(4):592–595
  26. Mikic D, Djokic M, Bojic I, Pavlovic M, Balint B, Vucinic Z, et al. Severe malaria falciparum associated with endocarditis. Vojnosanit Pregl. 2001;58:689–694
  27. Ostojic G, Balint B, Urosevic I, Pavlovic M, Mikic M, Ristic L, et al. Red blood cell exchange – a novel therapeutic approach. Anest Reanim Transf. 2004;32(1–2):75–79
  28. Bierman HR, Marshall GJ, Kellz KH. Leukapheresis in man. III Haematologic observations in patients with leukemia and myeloid metaplasia. Blood. 1963;21:164–169
  29. Radovic M, Balint B, Djuric D, Taseski J, Milenkovic L, Krstic C, et al. Clinical application of therapeutic cytapheresis. Libri Oncol. 1990;19:15–19

PII: S1473-0502(06)00087-5

doi: 10.1016/j.transci.2006.03.001

Transfusion and Apheresis Science
Volume 35, Issue 1 , Pages 25-31 , August 2006

Article Tools